Acorah Software Products - Accounts Production 16.7.461 false true 31 December 2023 1 January 2023 false true No description of principal activity 1 January 2024 31 December 2024 31 December 2024 11505800 Mr John Curtis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11505800 2023-12-31 11505800 2024-12-31 11505800 2024-01-01 2024-12-31 11505800 frs-core:CurrentFinancialInstruments 2024-12-31 11505800 frs-core:Non-currentFinancialInstruments 2024-12-31 11505800 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11505800 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 11505800 frs-bus:Micro-entities 2024-01-01 2024-12-31 11505800 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 11505800 frs-bus:Director1 2024-01-01 2024-12-31 11505800 2022-12-31 11505800 2023-12-31 11505800 2023-01-01 2023-12-31 11505800 frs-core:CurrentFinancialInstruments 2023-12-31 11505800 frs-core:Non-currentFinancialInstruments 2023-12-31
Registered number: 11505800
Ashendon Capital Medical Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Martin Nye Limited
Chartered Certified Accountants
186 High Street
Winslow
Buckinghamshire
MK18 3DQ
Ashendon Capital Medical Limited
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 11505800
2024 2023
£ £
Fixed assets - 2,002,539
Current assets 1,271,010 275,604
Prepayments and accrued income - 8,785
Creditors: Amounts Falling Due Within One Year (546,989 ) (504,193 )
NET CURRENT ASSETS (LIABILITIES) 724,021 (219,804 )
TOTAL ASSETS LESS CURRENT LIABILITIES 724,021 1,782,735
Creditors: Amounts Falling Due After More Than One Year - (1,506,904 )
Accruals and deferred income (3,596 ) (41,485 )
NET ASSETS 720,425 234,346
CAPITAL AND RESERVES 720,425 234,346

Notes

1. General Information
Ashendon Capital Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11505800 . The registered office is 186 High Street, Winslow, Buckinghamshire, MK18 3DQ. The presentation currency is £ Sterling, rounded to the nearest £1.
The company transitioned from FRS 102 to FRS 105 during the year, the date of transition was 1st January 2022. As a result of the transition, investment properties were restated to their historic cost, previous revaluations on investment property amounting to £1,997,461 were reversed to profit and loss. Deferred tax on the revaluation amounting to £499,366  was also reversed to the profit and loss account. The net result of the transition was a reduction in the brought forward retained profit of £1,498,095.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
Page 0
Page 1
Ashendon Capital Medical Limited
Balance Sheet (continued)
As At 31 December 2024
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr John Curtis
Director
9th December 2025